Live Oak Bancshares Croissance future
Future contrôle des critères 5/6
Live Oak Bancshares is forecast to grow earnings and revenue by 32.4% and 21.1% per annum respectively. EPS is expected to grow by 31.4% per annum. Return on equity is forecast to be 13.2% in 3 years.
Informations clés
32.4%
Taux de croissance des bénéfices
31.4%
Taux de croissance du BPA
Banks croissance des bénéfices | 10.4% |
Taux de croissance des recettes | 21.1% |
Rendement futur des capitaux propres | 13.2% |
Couverture par les analystes | Low |
Dernière mise à jour | 28 Oct 2024 |
Mises à jour récentes de la croissance future
Recent updates
Live Oak Bancshares: Loan Originations Spike, But Credit Risk Worries
Oct 28Live Oak Bancshares: CD Related Costs Could Become A Tailwind
Jul 26Live Oak Bancshares: Time For A Downgrade
Dec 13Live Oak Bancshares: Solid Deposit Growth, But Expensive Price
Sep 21Live Oak Bancshares: Doubts About The Future
Jun 18Live Oak Bancshares GAAP EPS of $0.04 misses by $0.37, revenue of $104.97M misses by $7.04M
Jan 25Live Oak Bancshares: Slow Down Ahead But Topline Growth Likely To Remain Positive
Jan 19Live Oak Bancshares (NYSE:LOB) Ticks All The Boxes When It Comes To Earnings Growth
Jan 09Live Oak Bancshares, Inc. Just Beat Revenue Estimates By 27%
Oct 30Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 688 | 171 | N/A | N/A | 2 |
12/31/2025 | 590 | 134 | N/A | N/A | 3 |
12/31/2024 | 504 | 93 | N/A | N/A | 3 |
9/30/2024 | 406 | 84 | N/A | N/A | N/A |
6/30/2024 | 427 | 111 | 431 | 500 | N/A |
3/31/2024 | 409 | 101 | 494 | 553 | N/A |
12/31/2023 | 391 | 74 | 573 | 620 | N/A |
9/30/2023 | 372 | 60 | 443 | 476 | N/A |
6/30/2023 | 375 | 63 | 309 | 342 | N/A |
3/31/2023 | 482 | 142 | 92 | 127 | N/A |
12/31/2022 | 508 | 176 | 81 | 124 | N/A |
9/30/2022 | 539 | 205 | 76 | 113 | N/A |
6/30/2022 | 518 | 196 | 47 | 77 | N/A |
3/31/2022 | 448 | 162 | 51 | 74 | N/A |
12/31/2021 | 439 | 167 | -123 | -120 | N/A |
9/30/2021 | 396 | 166 | -133 | -111 | N/A |
6/30/2021 | 385 | 166 | -331 | -310 | N/A |
3/31/2021 | 305 | 107 | -227 | -206 | N/A |
12/31/2020 | 240 | 60 | -282 | -261 | N/A |
9/30/2020 | 229 | 37 | -434 | -425 | N/A |
6/30/2020 | 190 | 7 | -324 | -314 | N/A |
3/31/2020 | 181 | 8 | -505 | -480 | N/A |
12/31/2019 | 188 | 18 | -520 | -483 | N/A |
9/30/2019 | 174 | 22 | -541 | -487 | N/A |
6/30/2019 | 177 | 32 | -308 | -230 | N/A |
3/31/2019 | 188 | 41 | -143 | -60 | N/A |
12/31/2018 | 198 | 51 | -105 | 6 | N/A |
9/30/2018 | 273 | 113 | -28 | 113 | N/A |
6/30/2018 | 264 | 111 | N/A | -117 | N/A |
3/31/2018 | 252 | 107 | N/A | -216 | N/A |
12/31/2017 | 241 | 100 | N/A | -288 | N/A |
9/30/2017 | 163 | 34 | N/A | -304 | N/A |
6/30/2017 | 152 | 25 | N/A | -234 | N/A |
3/31/2017 | 135 | 15 | N/A | -236 | N/A |
12/31/2016 | 128 | 14 | N/A | -222 | N/A |
9/30/2016 | 120 | 14 | N/A | -243 | N/A |
6/30/2016 | 110 | 13 | N/A | -327 | N/A |
3/31/2016 | 112 | 17 | N/A | -379 | N/A |
12/31/2015 | 106 | 21 | N/A | -335 | N/A |
9/30/2015 | 94 | 17 | N/A | -374 | N/A |
6/30/2015 | 91 | 15 | N/A | -348 | N/A |
3/31/2015 | 81 | 18 | N/A | -284 | N/A |
12/31/2014 | 72 | 10 | N/A | -262 | N/A |
12/31/2013 | 56 | 28 | N/A | -44 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: LOB's forecast earnings growth (32.4% per year) is above the savings rate (2.5%).
Bénéfices vs marché: LOB's earnings (32.4% per year) are forecast to grow faster than the US market (15.4% per year).
Croissance élevée des bénéfices: LOB's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: LOB's revenue (21.1% per year) is forecast to grow faster than the US market (8.9% per year).
Croissance élevée des revenus: LOB's revenue (21.1% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: LOB's Return on Equity is forecast to be low in 3 years time (13.2%).